Companies and Markets
Call us on +44 (0) 203 086 8600
Market Research A to Z | Company Profiles A to Z | RegisterRegister | Contact UsContact Us | Shopping Basket Shopping Basket
+44 (0) 203 086 8600 Call us on

Global Vaccines Market 2010-2025

1499

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Site License

Site License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£1,499.00

Change Currency

GBP EURO USD

Market

Healthcare and Medical

Report Type

Market Research

Country

Global

Published

16 March 2010

Number of Pages

206

Report Delivery

Email

Delivery Lead Time

1-3 hours, 24 hour max

Publisher

Visiongain

File Format

PDF

In 2009, the global market for vaccines achieved sales of over $10bn. Hundreds of millions of people are affected by infectious diseases that can be fought by vaccination. Despite controversy, vaccine use remains one of the greatest successes in the fight against disease - one with a long history. This market will achieve sustained growth over the next 15 years, our new study reveals. Increasingly, governments recognize the benefits of mass vaccination, with successive vaccines delivering healthcare solutions on a large scale, a trend set to continue.

Global Vaccines Market 2010-2025 provides a detailed analysis of the human vaccines market, predicting how and why it will expand in coming years. Our study provides a detailed forecast of the existing market, dividing it into major groups, from pediatric vaccines to prophylactic cancer treatments. Our report shows the commercial potential of vaccine classes from 2010 to 2025. We examine the most-successful current vaccines in particular, forecasting their sales and discussing their prospects in detail.

Which vaccines will achieve blockbuster sales from 2010 onwards? Which classes will experience the fastest growth, and what will cause this market expansion? What are the greatest unmet needs in vaccine use? What are the principal market drivers and restraints? What conditions are most likely to benefit from vaccine solutions in future, especially disorders currently un-served or under-served by treatments? This report covers those and other crucial questions, providing the information that you need. Our new study examines the biotechnological possibilities, determining which companies and which products are best placed to succeed in the vaccines market.

Comprehensive analysis of the global vaccines market

Global Vaccines Market 2010-2025 examines that sector through a comprehensive review of information sources. We harness both primary and secondary research. This report provides unique sales forecasts, market share analyses, discussions of R&D pipeline developments and analyses of commercial drivers and restraints, including a SWOT analysis. There are 75 tables and figures included, as well as three original interviews with relevant experts. The result is a comprehensive market- and industry-centered study, with detailed analyses and informed opinion to benefit your work.

Why you should buy Global Vaccines Market 2010-2025

This report gives you the following benefits in particular:
• You will receive a comprehensive analysis of the prospects for vaccines from 2010 to 2025, including predicted revenues, growth rates and other data for leading products
• You will receive an overall forecast for the global vaccines market from 2010 to 2025, as well as those for main classes, with comprehensive discussions and other supporting information
• You will find out where the market is heading - both technologically and commercially - from 2010 onwards
• You will discover the prospects for leading companies from 2010 onwards
• You will identify key R&D pipeline developments and up-and-coming products
• You will analyse the drivers, restraints, competition and opportunities influencing the vaccines sector
• You will investigate under-met needs in that sector, with both therapeutic requirements and commercial opportunities discussed
• You will discover expert views from our survey, including full interview transcripts.

You can obtain this report today

Nobody with an interest in the vaccines sector should overlook this new study. We predict that total revenues will increase. Recent technological advances have led to high expectations for vaccines currently in development. With rising demand worldwide and currently-unmet needs, this market holds significant potential for technological innovation and revenue growth. Do you want to harness those opportunities?

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Site License

Site License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£1,499.00

Change Currency

GBP EURO USD

Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency

GBP
USD

Use our research skills: Get free support

Free Research Support: Let us do the work for you and find information from public and private sources of information. Contact us now and we can save you time and money.......Free Research Support

eBrandPromote: Get your brands ranked highly online

eBrandPromote: Let us promote your brand online through article writing, press release distribution, social media and search engine marketing services. Click here to download our eBrandPromote brochure.

Accessibility
Close

Contrast settings

Text size settings